002950.SHE Allmed Medical Products Co Ltd Class A
- Market cap
- CNY 5.33B
- P/E
- 22.7x
- P/B
- 1.35x
- ROE
- 11.2%
- Dividend yield
- 0.98%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 002950.SHE undervalued?
Graham number002950.SHE trades 17.0% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Allmed Medical Products Co Ltd Class A fundamental analysis
No fundamental analysis for Allmed Medical Products Co Ltd Class A yet.
Allmed Medical Products Co Ltd Class A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Allmed Medical Products Co Ltd Class A
Allmed Medical Products Co.,Ltd supplier in medical dressings and infection control solutions in China and internationally. The company offers traditional wound care products include nonwoven and woven gauze swabs, non-adherent pads, drain sponges, abdominal pads, fluffy sponges/bandages, woven gauze and nonwoven gauze balls, eye pads, cotton filled exodontia sponges, packing strips, ribbon gauze, cotton tipped applicators, elastic net bandages, nose bandages, instrument cov…
Full company profileAllmed Medical Products Co Ltd Class A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Allmed Medical Products Co Ltd Class A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.56B | 1.71B | 2.03B | 2.35B | 3.83B | 2.93B | 4.21B | 2.76B | 3.33B | 3.67B | 3.84B |
| Gross Profit | 556M | 575M | 632M | 777M | 1.61B | 872M | 1.40B | 658M | 928M | 1.05B | 1.18B |
| Operating Income | 284M | 283M | 278M | 391M | 1.34B | 506M | 525M | 169M | 458M | 595M | 647M |
| EBITDA | 391M | 394M | 427M | 558M | 1.50B | 674M | 719M | 426M | 709M | 569M | 541M |
| Net Income | 248M | 234M | 228M | 326M | 1.16B | 431M | 407M | 110M | 369M | 249M | 428M |
| EPS | 0.43 | 0.42 | 0.41 | 0.53 | 1.83 | 0.68 | 0.64 | 0.17 | 0.59 | 0.39 | 0.68 |
| Balance Sheet | |||||||||||
| Total Assets | 1.90B | 2.27B | 2.90B | 3.16B | 4.86B | 5.00B | 5.75B | 5.08B | 5.06B | 5.61B | 6.30B |
| Total Liabilities | 879M | 1.17B | 1.58B | 1.10B | 1.93B | 2.25B | 2.62B | 1.87B | 1.61B | 1.99B | 2.44B |
| Shareholders' Equity | 1.01B | 1.09B | 1.31B | 2.05B | 2.91B | 2.75B | 3.10B | 3.19B | 3.44B | 3.60B | 3.83B |
| Cash & Short-term Investments | 310M | 200M | 310M | 244M | 1.34B | 687M | 787M | 494M | 668M | 968M | 530M |
| Total Debt | 443M | 636M | 1.07B | 583M | 1.19B | 1.29B | 933M | 900M | 584M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 473M | 197M | 3.01M | 273M | 1.44B | 375M | 1.15B | 424M | 712M | 717M | - |
| Capital Expenditure | 160M | 406M | 287M | 233M | 243M | 291M | 398M | 286M | 157M | 260M | 458M |
| Free Cash Flow | 312M | -208M | -284M | 40.6M | 1.19B | 84.2M | 752M | 137M | 555M | 457M | -309M |
| Ratios | |||||||||||
| ROE | 24.6% | 21.5% | 17.4% | 15.9% | 39.8% | 15.7% | 13.1% | 3.5% | 10.7% | 6.9% | 11.2% |
| ROA | 13.1% | 10.3% | 7.9% | 10.3% | 23.8% | 8.6% | 7.1% | 2.2% | 7.3% | 4.4% | 6.8% |
| Net Profit Margin | 15.9% | 13.7% | 11.2% | 13.8% | 30.2% | 14.7% | 9.7% | 4.0% | 11.1% | 6.8% | 11.1% |
| Debt to Equity | 0.44x | 0.59x | 0.82x | 0.28x | 0.41x | 0.47x | 0.30x | 0.28x | 0.17x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Allmed Medical Products Co Ltd Class A dividends
- Dividend yield
- 0.98%
- Forward dividend
- 0.15 CNY
- Payout ratio
- 21.0%
- Ex-dividend date
- Jun 24, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 52.3M | 0.08 | 21.0% |
| 2024 | CNY 44.1M | 0.07 | 12.0% |
| 2023 | CNY 65.2M | 0.10 | 59.1% |
| 2022 | CNY 133M | 0.21 | 32.7% |
| 2021 | CNY 557M | 0.88 | 129.2% |
| 2020 | CNY 253M | 0.40 | 21.9% |
| 2019 | CNY 63.3M | 0.10 | 19.4% |
| 2018 | CNY 35.1M | 0.06 | 15.4% |
| 2017 | CNY 186M | 0.33 | 79.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.5:1 on Jun 5, 2020.
Who owns Allmed Medical Products Co Ltd Class A
- Insiders 62.43%
- Institutions 2.33%
- Public & others 35.24%
- Shares outstanding 633M
- Free float 219M
Allmed Medical Products Co Ltd Class A company profile
- Company name
- Allmed Medical Products Co Ltd Class A
- Ticker
- 002950.SHE
- ISIN
- CNE100003JM5
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 6,158
- Fiscal year end
- December
- Address
- No. 18, Qixing Avenue, Zhijiang, China, 443200
- Phone
- 86 75 5882 99832
- Website
- allmed.cn
About Allmed Medical Products Co Ltd Class A
Allmed Medical Products Co.,Ltd supplier in medical dressings and infection control solutions in China and internationally. The company offers traditional wound care products include nonwoven and woven gauze swabs, non-adherent pads, drain sponges, abdominal pads, fluffy sponges/bandages, woven gauze and nonwoven gauze balls, eye pads, cotton filled exodontia sponges, packing strips, ribbon gauze, cotton tipped applicators, elastic net bandages, nose bandages, instrument covers, impregnated gauze dressings, adhesive dressings and tapes, wound bandages, kits, and precut gamgee. It also provides advanced wound care products consist of hydrocolloid dressings, hydrocolloid bandages, blister dressings, silicone foam dressings, superabsorbent dressings, silicone scar patches, and alginate dressings; OR consumables, include x-ray woven gauze/nonwoven gauze swabs and balls, neuro and laparotomy sponges, OR towels, and disposable towel drapes. In addition, the company offers infection products, such as SMS fabric, sterilization wraps, surgical gowns, drapes, surgical packs, normal isolation gowns, isolation gowns (various levels), masks, surgical caps, shoe covers, and boot covers. Allmed Medical Products Co.,Ltd was founded in 1997 and is based in Zhijiang, the People's Republic of China.
Allmed Medical Products Co Ltd Class A management
8- Mr. Jinhai CuiChairman of the Board & President · born 1959
- Mr. Tiezhu HuangVP & CFO · born 1975
- Ms. Hong ChengVice President · born 1968
- Ms. Chunjing ChenVice President · born 1975
- Mr. Hui CuiVP & Non-Independent Director · born 1983
- Mr. Xingwei CuiVP & Non-Independent Director · born 1994
- Mr. Xiaocheng ZhengCompany Secretary · born 1992
- Tongshan ChenAccounting Supervisor